Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
life sciences
5
×
national blog main
biotech
boston blog main
new york blog main
san diego blog main
san diego top stories
amgen
atrial fibrillation
boston scientific
boston top stories
clinical trials
fda
national
national top stories
new york top stories
san francisco blog main
san francisco top stories
8vc
abaloparatide
abbott
acc
acqmap
acquisition
activist investor
acutus
aducanumab
advent venture partners
alirocumab
alnylam pharmaceuticals
alzheimer's failure
american college of cardiology
amyloid
andreas grauer
apple watch
biohaven
biotronik
black box
black box warning
boston
What
heart
5
×
drug
help
time
acquire
acutus
adding
adds
adu
alnylam
amgen
amgen’s
approval
approved
atrial
based
beats
bids
bio
biogen
boston
business
carries
cholesterol
company
complicated
continues
cryterion
data
deal
depression
developed
device
dire
doctors
electrophysiology
europe
european
evidence
fibrillation
Language
unset
Current search:
heart
×
photo
×
" life sciences "
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
